Tranexamic acid in the adult trauma patient

    loading  Checking for direct PDF access through Ovid

Abstract

Tranexamic acid (TXA) is an antifibrinolytic agent that has been shown to decrease mortality in trauma patients at risk for or actively bleeding. This article discusses the risks and benefits of using I.V. TXA to treat patients with traumatic injuries and critical assessment considerations for critical care nurses caring for patients who may be candidates for this therapy.

Related Topics

    loading  Loading Related Articles